IP Library Granted Patent US 9,315,787
Granted Patent B2
US 9,315,787 · App. 13/979,509 · Granted Apr 19, 2016

Modified DNA polymerases for improved amplification

Inventors: Wolfgang Schafer (Western Cape, ZA); Paul McEwan (Western Cape, ZA); Eric Van Der Walt (Western Cape, ZA); John Foskett (Western Cape, ZA); William Bourn (Western Cape, ZA)
Assignee: KAPA BIOSYSTEMS, INC.
C12N9/1252C12P19/34C12Q1/686C12Y207/07007Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,315,787
App. No.
13/979,509
Granted
Apr 19, 2016
Kind
B2
Abstract

The present invention provides improved DNA polymerases that may be better suited for applications in recombinant DNA technologies, in particular technologies involving plant-derived samples. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.

Claims (23)

1. A DNA polymerase whose amino acid sequence is at least 95% identical to that of SEQ ID NO:38, but differs from SEQ ID NO:38 at a position corresponding to F749 of SEQ ID NO:38 and furthermore differs from SEQ ID NO:38 by at least two additional amino acids at positions corresponding to at least two of A61, K346, 5357, E507 or I707 of SEQ ID NO:38.

2. The DNA polymerase of claim 1 , wherein the amino acid at a position corresponding to F749 of SEQ ID NO: 38, is selected from the group consisting of L, I, V, T, Y, and M.

3. The DNA polymerase of claim 1 , wherein the amino acid at a position corresponding to 749 of SEQ ID NO: 38 is L, and the at least two additional amino acids correspond to amino acids in SEQ ID NO: 38, but are substitutions relative to SEQ ID NO: 38 and are selected from the group consisting of: A61T, K346E, S357C, E507K, I707M and combinations thereof.

4. The DNA polymerase of claim 3 , wherein the DNA polymerase has increased resistance to a plant-derived PCR inhibitor as compared to that of SEQ ID NO: 38.

5. A formulation of DNA polymerases comprising:

(i) a DNA polymerase whose amino acid sequence is at least 95% identical to that of SEQ ID NO: 38, but differs from SEQ ID NO: 38 by an amino acid at a position corresponding to F749 of SEQ ID NO:38; and furthermore differs from SEQ ID NO: 38 by at least two additional amino acids at positions corresponding to at least two of A61, K346, S357, E507 or I707 of SEQ ID NO:38; and

(ii) at least one DNA polymerase exhibiting 3′-exonuclease activity.

6. The formulation of claim 5 , wherein the DNA polymerase and the at least one DNA polymerase exhibiting 3′-exonuclease activity are present in a ratio of about 1:1 to about 1:2000 relative units of enzyme.

7. A method comprising a step of amplifying nucleic acids in a biological sample using:

(i) a DNA polymerase whose amino acid sequence is at least 95% identical to that of SEQ ID NO: 38, but differs from SEQ ID NO: 38 by an amino acid at a position corresponding to F749 of SEQ ID NO:38; and furthermore differs from SEQ ID NO: 38 by at least two additional amino acids at positions corresponding to at least two of A61, K346, S357, E507, or I707 of SEQ ID NO:38; and

(ii) at least one additional DNA polymerase, wherein the least one additional DNA polymerase has 3′-exonuclease activity.

8. The method of claim 7 , wherein the biological sample includes purified DNA or a crude DNA extract.

9. The method of claim 7 , wherein the biological sample is a plant sample.

10. The method of claim 9 , wherein the plant sample is selected from the group consisting of: leaf tissue, seed tissue, plant tissue, organ tissue, stored plant sample, crude plant DNA extract, and combinations thereof.

11. The method of claim 7 , wherein the DNA polymerase and the at least one additional DNA polymerase are present in a ratio of about 1:1 to about 1:2000 relative units of enzyme.

12. The DNA polymerase of claim 1 , whose amino acid sequence is at least 96% identical to that of SEQ ID NO: 38.

13. The DNA polymerase of claim 1 , whose amino acid sequence is at least 97% identical to that of SEQ ID NO: 38.

14. The DNA polymerase of claim 1 , whose amino acid sequence is at least 98% identical to that of SEQ ID NO: 38.

15. The DNA polymerase of claim 3 , wherein the DNA polymerase has increased resistance to salt relative to that of SEQ ID NO: 38.

16. A DNA polymerase whose amino acid sequence is that of SEQ ID NO: 47.

17. A DNA polymerase whose amino acid sequence is that of SEQ ID NO: 48.

18. A DNA polymerase whose amino acid sequence is at least 98% identical to that of SEQ ID NO: 47, including in that it has I at a position corresponding to F749 of SEQ ID NO: 38, and in that it has at least two other amino acid substitutions at positions relative to wild type DNA polymerase of SEQ ID NO: 38, which positions are selected from the group consisting of 61, 346, 357, 507, 707, and combinations thereof.

19. A DNA polymerase whose amino acid sequence is at least 98% identical to that of SEQ ID NO: 48, including in that it has L at a position corresponding to F749 of SEQ ID NO: 38 and in that it has at least two other amino acid substitutions at positions relative to wild type DNA polymerase of SEQ ID NO: 38, which positions are selected from the group consisting of 61, 346, 357, 507, 707 and combinations thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2015
From: KAPA BIOSYSTEMS; KAPABIOSYSTEMS; KAPABIOSYSTEMS ET AL
To: KAPA BIOSYSTEMS, INC.
Reel/Frame 036139/0870 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF INVENTOR BOURN'S LAST NAME PREVIOUSLY RECORDED ON REEL 031126 FRAME 0788. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT SPELLING IS WILLIAM BOURN. Recorded Oct 17, 2013
From: SCHAFER, WOLFGANG; MCEWAN, PAUL; VAN DER WALT, ERIC; FOSKETT, JOHN; BOURN, WILLIAM
To: KAPA BIOSYSTEMS
Reel/Frame 031431/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: SCHAFER, WOLFGANG; MCEWAN, PAUL; VAN DER WALT, ERIC; FOSKETT, JOHN; BOURNE, WILLIAM
To: KAPA BIOSYSTEMS
Reel/Frame 031126/0788 →
Continuity (2)
Provisional Application 61432936 · Jan 14, 2011
Related Publication 20140030765A1 · Jan 30, 2014